2008T and 2008TBluestar Hemodialysis Machines with CDX-Indicated for acute and chronic dialysis ...

FDA Device Recall #Z-0734-2023 — Class II — July 27, 2022

Recall Summary

Recall Number Z-0734-2023
Classification Class II — Moderate risk
Date Initiated July 27, 2022
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Fresenius Medical Care Holdings, Inc.
Location Waltham, MA
Product Type Devices
Quantity 2008T with CDX= 70,552 2008T Bluestar with CDX= 25,205

Product Description

2008T and 2008TBluestar Hemodialysis Machines with CDX-Indicated for acute and chronic dialysis therapy in a healthcare facility Models: (1) 190713 2008T HEMODIALYSIS SYS., with CDX; (2) 190766 2008T HEMODIALYSIS SYSTEM W/BIBAG W/CDX ; (3) 191124 2008T HD SYS. CDX BLUESTAR; (4) 191126 2008T HD SYS. CDX W/BIBAG BLUESTAR

Reason for Recall

(1)Software version 2.74 upgrade and (2)hardware related cause that affects only CDX Machines, has been identified as the UI-MICs Board is sensitive to Electromagnetic Interference (EMI) which will cause the false alarm "Remove USB 2 Device".

Distribution Pattern

US Nationwide distribution.

Lot / Code Information

Software issue in SW versions 2.72 and earlier with CDX. UDI: (1) 00840861100897; (2) 00840861100910; (3) 00840861102082; (4) 00840861102099

Other Recalls from Fresenius Medical Care Holdings, Inc.

Recall # Classification Product Date
Z-0936-2026 Class II 5008X CAREsystem +CLiC +CDX; Oct 25, 2025
Z-0041-2026 Class II Optiflux¿ High Flux E-beam Dialyzer Model Numb... Aug 29, 2025
Z-1992-2025 Class II 5008X HDF Hemodialysis Blood Tubing Set, 24 uni... Apr 29, 2025
Z-0801-2025 Class II Dialyzer Optiflux 160NRe Dec 5, 2024
Z-3124-2024 Class II Blood Pressure Module BPM3 TM-2917B (Spare Part... Aug 8, 2024

Frequently Asked Questions

A software recall means the device's embedded software or firmware has a defect that could affect its performance or safety. Many software recalls are corrected through firmware updates that can be applied without physically replacing the device. For implantable devices, the update may be delivered wirelessly during a routine clinic visit. For external devices, the manufacturer may provide updated software files or replacement units. Contact your healthcare provider to determine whether your specific device and software version are affected and what action is recommended.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.